InformAI is a technology company dedicated to advancing healthcare through the development of AI-driven solutions.

InformAI

Gesund.ai empowers medical AI developers to establish, optimize, and sustain their AI lifecycles, ensuring privacy, compliance, speed, and scalability.

Gesund.ai

InformAI | 738 followers on LinkedIn. Advancing Healthcare Through Informatics | InformAI is a technology company dedicated to advancing healthcare through the development of AI-driven solutions.

CEO at InformAI

Jim Havelka

CEO at Cal.net Inc.

Jack Barker

Data, AI @ InformAI | Rice MBA, MSc Biomedical Engineering

Britton Marlatt

Chief Medical Officer, Healthcare entrepreneur , startup mentor, angel investor, board advisor, AI innovator

Dr. Anil Shetty

InformAI is happy to celebrate International Rural Health Day today. AI solutions can address healthcare disparities. We are developing a radiation #oncology product to enable junior clinicians to create plans of senior specialist quality, enhancing care in rural and non-academic settings. We are proud to do our part to enable better #healthcare for our rural communities.

InformAI is pleased to be nominated by Houston Innovation Map @InnoMapHou in the health tech business category honoring an innovative startup within the health and medical technology. Thanks! It's an honor! https://lnkd.in/gM2Fq7xg

InformAI is pleased to participate alongside advisor Dr. David Sher in #Chartrounds October 28 session on personalizing #radiotherapy with optimized treatment plans: https://lnkd.in/grxSr2gb Chartrounds has over 6,000 worldwide members, and brings together academic disease site physician specialists and medical physicists to discuss treatment plans in rural and community-based hospitals. Read the Chartrounds story here: https://lnkd.in/ghetaSgy

AuntMinnie.com has published its list of biggest threats to #radiology for 2024. Vastly increasing imaging volumes, as well as radiologist shortages and burnout top the list. Slow adoption rate for #AI is also a threat, but it shouldn't be, as AI tools can greatly help deal with the other threats. AI tools help streamline imaging workflows for #radiologists , and we're proud to do our part in developing AI solutions.

#InformAI is pleased to be a funded company at Cancer Prevention and Research Institute of Texas . Thanks to our #CPRIT Project Manager, Abria Magee, for featuring our work on AI-Enabled Dose Planning Tool for Radiation Oncology at the #AI in #Healthcare Conference at Rice University . More info on the conference: https://lnkd.in/gVswXmFt

The Cancer Prevention and Research Institute of Texas (CPRIT) is a $6 billion, 20-year initiative to fight cancer. It is the largest state cancer research investment in the history of the United States and the second largest cancer research and prevention program in the world. CPRIT awards Product Development grants for the delivery of evidence-based cancer prevention services. InformAI is a proud recipient of a product development grant. CPRIT matters to Texas and the world. Here’s why: https://lnkd.in/gT4qWQ_p

Thanks TMC Innovation for sharing our #NIH progress in the June newsletter. https://lnkd.in/grqb_PzS

InformAI is proud to be a #Nvidia Inception Partner. Congrats Renee on this great article. NVIDIA In Healthcare: From Gaming To Medicine - The Medical Futurist https://bit.ly/4brNH7R

We love being based in Houston, one of the world’s top 50 startup cities on a new list from PitchBook! Houston earned a Pitchbook growth score of 63.8/100 — the highest growth score of any US city and the seventh highest growth score in the world. Houston sits between between Paris (64.4) and Washington, D.C. (61.7). The PitchBook growth score reflects short-term, midterm, and long-term growth momentum for activity surrounding venture capital deals, exits, and fundraising for the past six years. https://lnkd.in/gsehXM9Z

InformAI is happy to help spread awareness about organ donation during April's National Donate Life month. Participation is more important than ever. Nearly 104,000 Americans are on the national organ transplant waiting list, and a new name is added every 8 minutes. One person can save up to 8 lives through organ donation and improve over 75 lives through tissue and cornea donation. To learn more about donation, please visit LifeGift.org or DonateLifeTexas.org .

Metric
Company Name	InformAI	Gesund.ai
Symbol
MSH ID	COM:INFORMAI	AI:GESUND
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Health Technology	Healthcare Technology
Country	US	DE
Stage	Seed
Employee Count
Website	informai.com	gesund.ai
LinkedIn	informai-inc	gesund-ai
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	176	176
Web Traffic Growth		-0.50
Valuation
Raised Capital	1.50M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

INFO

COM:INFORMAI

InformAI

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue